Although the reason for this remains unclear, hypotheses have included the expression of progesterone and estrogen receptors in meningioma, tumor growth under progesterone agonist therapy, or in women using hormone replacement therapy or oral contraceptives (6, 7). The gene discussed is ESR1; the disease is meningioma.